WO2011018995A1 - Hydrogel composite organique/inorganique et son procédé de production - Google Patents
Hydrogel composite organique/inorganique et son procédé de production Download PDFInfo
- Publication number
- WO2011018995A1 WO2011018995A1 PCT/JP2010/063371 JP2010063371W WO2011018995A1 WO 2011018995 A1 WO2011018995 A1 WO 2011018995A1 JP 2010063371 W JP2010063371 W JP 2010063371W WO 2011018995 A1 WO2011018995 A1 WO 2011018995A1
- Authority
- WO
- WIPO (PCT)
- Prior art keywords
- organic
- compound
- inorganic composite
- composite hydrogel
- clay mineral
- Prior art date
Links
- 239000000017 hydrogel Substances 0.000 title claims abstract description 98
- 239000002131 composite material Substances 0.000 title claims abstract description 86
- 238000004519 manufacturing process Methods 0.000 title claims abstract description 9
- 239000002734 clay mineral Substances 0.000 claims abstract description 69
- 229920001223 polyethylene glycol Polymers 0.000 claims abstract description 59
- 239000002202 Polyethylene glycol Substances 0.000 claims abstract description 54
- 102000004169 proteins and genes Human genes 0.000 claims abstract description 42
- 108090000623 proteins and genes Proteins 0.000 claims abstract description 42
- 239000000463 material Substances 0.000 claims abstract description 19
- 125000003827 glycol group Chemical group 0.000 claims abstract description 17
- 238000000354 decomposition reaction Methods 0.000 claims abstract description 16
- 239000007943 implant Substances 0.000 claims abstract description 4
- 150000001875 compounds Chemical class 0.000 claims description 80
- 229920000642 polymer Polymers 0.000 claims description 40
- 125000000524 functional group Chemical group 0.000 claims description 23
- 125000004185 ester group Chemical group 0.000 claims description 22
- 238000000034 method Methods 0.000 claims description 17
- XPPKVPWEQAFLFU-UHFFFAOYSA-N diphosphoric acid Chemical compound OP(O)(=O)OP(O)(O)=O XPPKVPWEQAFLFU-UHFFFAOYSA-N 0.000 claims description 13
- 238000006243 chemical reaction Methods 0.000 claims description 9
- 229940005657 pyrophosphoric acid Drugs 0.000 claims description 9
- 239000006185 dispersion Substances 0.000 claims description 7
- 230000008569 process Effects 0.000 claims description 3
- 239000012736 aqueous medium Substances 0.000 claims description 2
- 230000029983 protein stabilization Effects 0.000 claims description 2
- 239000012298 atmosphere Substances 0.000 abstract description 9
- 231100000252 nontoxic Toxicity 0.000 abstract description 2
- 230000003000 nontoxic effect Effects 0.000 abstract description 2
- 229920002521 macromolecule Polymers 0.000 abstract 1
- 238000000926 separation method Methods 0.000 abstract 1
- 239000000499 gel Substances 0.000 description 74
- XLYOFNOQVPJJNP-UHFFFAOYSA-N water Substances O XLYOFNOQVPJJNP-UHFFFAOYSA-N 0.000 description 45
- 235000018102 proteins Nutrition 0.000 description 36
- 230000000052 comparative effect Effects 0.000 description 29
- 102000004190 Enzymes Human genes 0.000 description 28
- 108090000790 Enzymes Proteins 0.000 description 28
- 229940088598 enzyme Drugs 0.000 description 28
- 239000007864 aqueous solution Substances 0.000 description 25
- VEXZGXHMUGYJMC-UHFFFAOYSA-N Hydrochloric acid Chemical compound Cl VEXZGXHMUGYJMC-UHFFFAOYSA-N 0.000 description 22
- 230000000694 effects Effects 0.000 description 17
- 239000004927 clay Substances 0.000 description 15
- 239000000203 mixture Substances 0.000 description 15
- 239000000243 solution Substances 0.000 description 15
- FQENQNTWSFEDLI-UHFFFAOYSA-J sodium diphosphate Chemical compound [Na+].[Na+].[Na+].[Na+].[O-]P([O-])(=O)OP([O-])([O-])=O FQENQNTWSFEDLI-UHFFFAOYSA-J 0.000 description 12
- 229940094522 laponite Drugs 0.000 description 11
- XCOBTUNSZUJCDH-UHFFFAOYSA-B lithium magnesium sodium silicate Chemical compound [Li+].[Li+].[OH-].[OH-].[OH-].[OH-].[OH-].[OH-].[OH-].[OH-].[OH-].[OH-].[OH-].[OH-].[Na+].[Na+].[Mg+2].[Mg+2].[Mg+2].[Mg+2].[Mg+2].[Mg+2].[Mg+2].[Mg+2].[Mg+2].[Mg+2].[Mg+2].[Mg+2].[Mg+2].[Mg+2].[Mg+2].[Mg+2].O1[Si](O2)([O-])O[Si]3([O-])O[Si]1([O-])O[Si]2([O-])O3.O1[Si](O2)([O-])O[Si]3([O-])O[Si]1([O-])O[Si]2([O-])O3.O1[Si](O2)([O-])O[Si]3([O-])O[Si]1([O-])O[Si]2([O-])O3.O1[Si](O2)([O-])O[Si]3([O-])O[Si]1([O-])O[Si]2([O-])O3.O1[Si](O2)([O-])O[Si]3([O-])O[Si]1([O-])O[Si]2([O-])O3.O1[Si](O2)([O-])O[Si]3([O-])O[Si]1([O-])O[Si]2([O-])O3 XCOBTUNSZUJCDH-UHFFFAOYSA-B 0.000 description 11
- 239000000047 product Substances 0.000 description 11
- NBIIXXVUZAFLBC-UHFFFAOYSA-N Phosphoric acid Chemical compound OP(O)(O)=O NBIIXXVUZAFLBC-UHFFFAOYSA-N 0.000 description 10
- 241001662443 Phemeranthus parviflorus Species 0.000 description 8
- 230000015556 catabolic process Effects 0.000 description 8
- 238000004132 cross linking Methods 0.000 description 8
- 238000006731 degradation reaction Methods 0.000 description 8
- 229940048086 sodium pyrophosphate Drugs 0.000 description 8
- 235000019818 tetrasodium diphosphate Nutrition 0.000 description 8
- 239000001577 tetrasodium phosphonato phosphate Substances 0.000 description 8
- 239000000872 buffer Substances 0.000 description 7
- 230000003993 interaction Effects 0.000 description 7
- -1 polycaptolactone Polymers 0.000 description 7
- 230000015572 biosynthetic process Effects 0.000 description 6
- 239000007788 liquid Substances 0.000 description 6
- 238000009864 tensile test Methods 0.000 description 6
- LYCAIKOWRPUZTN-UHFFFAOYSA-N Ethylene glycol Chemical compound OCCO LYCAIKOWRPUZTN-UHFFFAOYSA-N 0.000 description 5
- 229910000147 aluminium phosphate Inorganic materials 0.000 description 5
- 238000001727 in vivo Methods 0.000 description 5
- 238000005259 measurement Methods 0.000 description 5
- 238000012360 testing method Methods 0.000 description 5
- VYPSYNLAJGMNEJ-UHFFFAOYSA-N Silicium dioxide Chemical compound O=[Si]=O VYPSYNLAJGMNEJ-UHFFFAOYSA-N 0.000 description 4
- 125000003368 amide group Chemical group 0.000 description 4
- 230000008859 change Effects 0.000 description 4
- 229920003020 cross-linked polyethylene Polymers 0.000 description 4
- 239000004703 cross-linked polyethylene Substances 0.000 description 4
- 231100000135 cytotoxicity Toxicity 0.000 description 4
- 230000003013 cytotoxicity Effects 0.000 description 4
- 231100000263 cytotoxicity test Toxicity 0.000 description 4
- 235000011180 diphosphates Nutrition 0.000 description 4
- 238000010571 fourier transform-infrared absorption spectrum Methods 0.000 description 4
- 239000011521 glass Substances 0.000 description 4
- 229910052739 hydrogen Inorganic materials 0.000 description 4
- 239000001257 hydrogen Substances 0.000 description 4
- 239000010410 layer Substances 0.000 description 4
- 229920000620 organic polymer Polymers 0.000 description 4
- 239000002504 physiological saline solution Substances 0.000 description 4
- 229940048084 pyrophosphate Drugs 0.000 description 4
- 239000011734 sodium Substances 0.000 description 4
- 239000000126 substance Substances 0.000 description 4
- 230000002194 synthesizing effect Effects 0.000 description 4
- ZWEHNKRNPOVVGH-UHFFFAOYSA-N 2-Butanone Chemical compound CCC(C)=O ZWEHNKRNPOVVGH-UHFFFAOYSA-N 0.000 description 3
- CSCPPACGZOOCGX-UHFFFAOYSA-N Acetone Chemical compound CC(C)=O CSCPPACGZOOCGX-UHFFFAOYSA-N 0.000 description 3
- 102000008186 Collagen Human genes 0.000 description 3
- 108010035532 Collagen Proteins 0.000 description 3
- 241000871495 Heeria argentea Species 0.000 description 3
- 108010001336 Horseradish Peroxidase Proteins 0.000 description 3
- OKKJLVBELUTLKV-UHFFFAOYSA-N Methanol Chemical compound OC OKKJLVBELUTLKV-UHFFFAOYSA-N 0.000 description 3
- ZMXDDKWLCZADIW-UHFFFAOYSA-N N,N-Dimethylformamide Chemical compound CN(C)C=O ZMXDDKWLCZADIW-UHFFFAOYSA-N 0.000 description 3
- 230000005540 biological transmission Effects 0.000 description 3
- 229920001436 collagen Polymers 0.000 description 3
- 239000007857 degradation product Substances 0.000 description 3
- 238000011156 evaluation Methods 0.000 description 3
- 230000002209 hydrophobic effect Effects 0.000 description 3
- 239000011259 mixed solution Substances 0.000 description 3
- 238000002156 mixing Methods 0.000 description 3
- 239000000178 monomer Substances 0.000 description 3
- 239000007787 solid Substances 0.000 description 3
- 238000003786 synthesis reaction Methods 0.000 description 3
- 238000002411 thermogravimetry Methods 0.000 description 3
- AZJYLVAUMGUUBL-UHFFFAOYSA-A u1qj22mc8e Chemical compound [F-].[F-].[F-].[F-].[F-].[F-].[F-].[F-].[F-].[F-].[F-].[F-].[F-].[F-].[F-].[F-].[F-].[F-].[Na+].[Na+].[Na+].[Na+].[Na+].[Na+].[Na+].[Na+].[Na+].[Na+].[Mg+2].[Mg+2].[Mg+2].[Mg+2].[Mg+2].[Mg+2].[Mg+2].[Mg+2].[Mg+2].[Mg+2].[Mg+2].[Mg+2].[Mg+2].[Mg+2].[Mg+2].[Mg+2].O=[Si]=O.O=[Si]=O.O=[Si]=O.O1[Si](O2)([O-])O[Si]3([O-])O[Si]1([O-])O[Si]2([O-])O3.O1[Si](O2)([O-])O[Si]3([O-])O[Si]1([O-])O[Si]2([O-])O3.O1[Si](O2)([O-])O[Si]3([O-])O[Si]1([O-])O[Si]2([O-])O3.O1[Si](O2)([O-])O[Si]3([O-])O[Si]1([O-])O[Si]2([O-])O3.O1[Si](O2)([O-])O[Si]3([O-])O[Si]1([O-])O[Si]2([O-])O3.O1[Si](O2)([O-])O[Si]3([O-])O[Si]1([O-])O[Si]2([O-])O3 AZJYLVAUMGUUBL-UHFFFAOYSA-A 0.000 description 3
- 238000005406 washing Methods 0.000 description 3
- 102000009027 Albumins Human genes 0.000 description 2
- 108010088751 Albumins Proteins 0.000 description 2
- 239000004382 Amylase Substances 0.000 description 2
- 102000013142 Amylases Human genes 0.000 description 2
- 108010065511 Amylases Proteins 0.000 description 2
- 102000015081 Blood Coagulation Factors Human genes 0.000 description 2
- 108010039209 Blood Coagulation Factors Proteins 0.000 description 2
- 108010059892 Cellulase Proteins 0.000 description 2
- 101710088194 Dehydrogenase Proteins 0.000 description 2
- IAZDPXIOMUYVGZ-UHFFFAOYSA-N Dimethylsulphoxide Chemical compound CS(C)=O IAZDPXIOMUYVGZ-UHFFFAOYSA-N 0.000 description 2
- LFQSCWFLJHTTHZ-UHFFFAOYSA-N Ethanol Chemical compound CCO LFQSCWFLJHTTHZ-UHFFFAOYSA-N 0.000 description 2
- 102000016359 Fibronectins Human genes 0.000 description 2
- 108010067306 Fibronectins Proteins 0.000 description 2
- 108010010803 Gelatin Proteins 0.000 description 2
- AEMRFAOFKBGASW-UHFFFAOYSA-N Glycolic acid Chemical compound OCC(O)=O AEMRFAOFKBGASW-UHFFFAOYSA-N 0.000 description 2
- 102000004882 Lipase Human genes 0.000 description 2
- 108090001060 Lipase Proteins 0.000 description 2
- 239000004367 Lipase Substances 0.000 description 2
- 102000004316 Oxidoreductases Human genes 0.000 description 2
- 108090000854 Oxidoreductases Proteins 0.000 description 2
- KDLHZDBZIXYQEI-UHFFFAOYSA-N Palladium Chemical compound [Pd] KDLHZDBZIXYQEI-UHFFFAOYSA-N 0.000 description 2
- 108091005804 Peptidases Proteins 0.000 description 2
- 239000004365 Protease Substances 0.000 description 2
- 102100037486 Reverse transcriptase/ribonuclease H Human genes 0.000 description 2
- FAPWRFPIFSIZLT-UHFFFAOYSA-M Sodium chloride Chemical compound [Na+].[Cl-] FAPWRFPIFSIZLT-UHFFFAOYSA-M 0.000 description 2
- WYURNTSHIVDZCO-UHFFFAOYSA-N Tetrahydrofuran Chemical compound C1CCOC1 WYURNTSHIVDZCO-UHFFFAOYSA-N 0.000 description 2
- GWEVSGVZZGPLCZ-UHFFFAOYSA-N Titan oxide Chemical compound O=[Ti]=O GWEVSGVZZGPLCZ-UHFFFAOYSA-N 0.000 description 2
- 238000002441 X-ray diffraction Methods 0.000 description 2
- MCMNRKCIXSYSNV-UHFFFAOYSA-N Zirconium dioxide Chemical compound O=[Zr]=O MCMNRKCIXSYSNV-UHFFFAOYSA-N 0.000 description 2
- 238000002835 absorbance Methods 0.000 description 2
- 150000001412 amines Chemical class 0.000 description 2
- 229940024606 amino acid Drugs 0.000 description 2
- 235000001014 amino acid Nutrition 0.000 description 2
- 150000001413 amino acids Chemical class 0.000 description 2
- 235000019418 amylase Nutrition 0.000 description 2
- 238000004458 analytical method Methods 0.000 description 2
- 239000000560 biocompatible material Substances 0.000 description 2
- 239000003114 blood coagulation factor Substances 0.000 description 2
- 229940019700 blood coagulation factors Drugs 0.000 description 2
- 229940106157 cellulase Drugs 0.000 description 2
- 238000010382 chemical cross-linking Methods 0.000 description 2
- 238000004140 cleaning Methods 0.000 description 2
- 230000000536 complexating effect Effects 0.000 description 2
- 229920001577 copolymer Polymers 0.000 description 2
- 239000012776 electronic material Substances 0.000 description 2
- 239000003822 epoxy resin Substances 0.000 description 2
- 230000001747 exhibiting effect Effects 0.000 description 2
- 239000008273 gelatin Substances 0.000 description 2
- 229920000159 gelatin Polymers 0.000 description 2
- 235000019322 gelatine Nutrition 0.000 description 2
- 235000011852 gelatine desserts Nutrition 0.000 description 2
- NAQMVNRVTILPCV-UHFFFAOYSA-N hexane-1,6-diamine Chemical compound NCCCCCCN NAQMVNRVTILPCV-UHFFFAOYSA-N 0.000 description 2
- WGCNASOHLSPBMP-UHFFFAOYSA-N hydroxyacetaldehyde Natural products OCC=O WGCNASOHLSPBMP-UHFFFAOYSA-N 0.000 description 2
- 238000002513 implantation Methods 0.000 description 2
- 230000006872 improvement Effects 0.000 description 2
- 235000019421 lipase Nutrition 0.000 description 2
- 230000014759 maintenance of location Effects 0.000 description 2
- 239000002609 medium Substances 0.000 description 2
- 239000013028 medium composition Substances 0.000 description 2
- 239000002105 nanoparticle Substances 0.000 description 2
- 239000003960 organic solvent Substances 0.000 description 2
- 239000005022 packaging material Substances 0.000 description 2
- 239000002245 particle Substances 0.000 description 2
- 239000008363 phosphate buffer Substances 0.000 description 2
- 230000000704 physical effect Effects 0.000 description 2
- BASFCYQUMIYNBI-UHFFFAOYSA-N platinum Chemical compound [Pt] BASFCYQUMIYNBI-UHFFFAOYSA-N 0.000 description 2
- 229920000647 polyepoxide Polymers 0.000 description 2
- 239000002861 polymer material Substances 0.000 description 2
- 235000019419 proteases Nutrition 0.000 description 2
- 239000000377 silicon dioxide Substances 0.000 description 2
- DAEPDZWVDSPTHF-UHFFFAOYSA-M sodium pyruvate Chemical compound [Na+].CC(=O)C([O-])=O DAEPDZWVDSPTHF-UHFFFAOYSA-M 0.000 description 2
- 230000000087 stabilizing effect Effects 0.000 description 2
- KIUKXJAPPMFGSW-DNGZLQJQSA-N (2S,3S,4S,5R,6R)-6-[(2S,3R,4R,5S,6R)-3-Acetamido-2-[(2S,3S,4R,5R,6R)-6-[(2R,3R,4R,5S,6R)-3-acetamido-2,5-dihydroxy-6-(hydroxymethyl)oxan-4-yl]oxy-2-carboxy-4,5-dihydroxyoxan-3-yl]oxy-5-hydroxy-6-(hydroxymethyl)oxan-4-yl]oxy-3,4,5-trihydroxyoxane-2-carboxylic acid Chemical compound CC(=O)N[C@H]1[C@H](O)O[C@H](CO)[C@@H](O)[C@@H]1O[C@H]1[C@H](O)[C@@H](O)[C@H](O[C@H]2[C@@H]([C@@H](O[C@H]3[C@@H]([C@@H](O)[C@H](O)[C@H](O3)C(O)=O)O)[C@H](O)[C@@H](CO)O2)NC(C)=O)[C@@H](C(O)=O)O1 KIUKXJAPPMFGSW-DNGZLQJQSA-N 0.000 description 1
- GEYOCULIXLDCMW-UHFFFAOYSA-N 1,2-phenylenediamine Chemical compound NC1=CC=CC=C1N GEYOCULIXLDCMW-UHFFFAOYSA-N 0.000 description 1
- OAHBNYJZYYTDNC-UHFFFAOYSA-N 1-hydroxypyrrolidine-2,5-dione;pentanedioic acid Chemical compound ON1C(=O)CCC1=O.OC(=O)CCCC(O)=O OAHBNYJZYYTDNC-UHFFFAOYSA-N 0.000 description 1
- VILCJCGEZXAXTO-UHFFFAOYSA-N 2,2,2-tetramine Chemical compound NCCNCCNCCN VILCJCGEZXAXTO-UHFFFAOYSA-N 0.000 description 1
- QKNYBSVHEMOAJP-UHFFFAOYSA-N 2-amino-2-(hydroxymethyl)propane-1,3-diol;hydron;chloride Chemical compound Cl.OCC(N)(CO)CO QKNYBSVHEMOAJP-UHFFFAOYSA-N 0.000 description 1
- UAIUNKRWKOVEES-UHFFFAOYSA-N 3,3',5,5'-tetramethylbenzidine Chemical compound CC1=C(N)C(C)=CC(C=2C=C(C)C(N)=C(C)C=2)=C1 UAIUNKRWKOVEES-UHFFFAOYSA-N 0.000 description 1
- 239000004475 Arginine Substances 0.000 description 1
- DCXYFEDJOCDNAF-UHFFFAOYSA-N Asparagine Natural products OC(=O)C(N)CC(N)=O DCXYFEDJOCDNAF-UHFFFAOYSA-N 0.000 description 1
- 241000894006 Bacteria Species 0.000 description 1
- 102000004506 Blood Proteins Human genes 0.000 description 1
- 108010017384 Blood Proteins Proteins 0.000 description 1
- 241000283707 Capra Species 0.000 description 1
- 229920001661 Chitosan Polymers 0.000 description 1
- 241000694440 Colpidium aqueous Species 0.000 description 1
- 102000004127 Cytokines Human genes 0.000 description 1
- 108090000695 Cytokines Proteins 0.000 description 1
- 238000012270 DNA recombination Methods 0.000 description 1
- RPNUMPOLZDHAAY-UHFFFAOYSA-N Diethylenetriamine Chemical compound NCCNCCN RPNUMPOLZDHAAY-UHFFFAOYSA-N 0.000 description 1
- KCXVZYZYPLLWCC-UHFFFAOYSA-N EDTA Chemical compound OC(=O)CN(CC(O)=O)CCN(CC(O)=O)CC(O)=O KCXVZYZYPLLWCC-UHFFFAOYSA-N 0.000 description 1
- PIICEJLVQHRZGT-UHFFFAOYSA-N Ethylenediamine Chemical compound NCCN PIICEJLVQHRZGT-UHFFFAOYSA-N 0.000 description 1
- 108090000288 Glycoproteins Proteins 0.000 description 1
- 102000003886 Glycoproteins Human genes 0.000 description 1
- 102000008015 Hemeproteins Human genes 0.000 description 1
- 108010089792 Hemeproteins Proteins 0.000 description 1
- DGAQECJNVWCQMB-PUAWFVPOSA-M Ilexoside XXIX Chemical compound C[C@@H]1CC[C@@]2(CC[C@@]3(C(=CC[C@H]4[C@]3(CC[C@@H]5[C@@]4(CC[C@@H](C5(C)C)OS(=O)(=O)[O-])C)C)[C@@H]2[C@]1(C)O)C)C(=O)O[C@H]6[C@@H]([C@H]([C@@H]([C@H](O6)CO)O)O)O.[Na+] DGAQECJNVWCQMB-PUAWFVPOSA-M 0.000 description 1
- ODKSFYDXXFIFQN-BYPYZUCNSA-P L-argininium(2+) Chemical compound NC(=[NH2+])NCCC[C@H]([NH3+])C(O)=O ODKSFYDXXFIFQN-BYPYZUCNSA-P 0.000 description 1
- DCXYFEDJOCDNAF-REOHCLBHSA-N L-asparagine Chemical compound OC(=O)[C@@H](N)CC(N)=O DCXYFEDJOCDNAF-REOHCLBHSA-N 0.000 description 1
- KDXKERNSBIXSRK-YFKPBYRVSA-N L-lysine Chemical compound NCCCC[C@H](N)C(O)=O KDXKERNSBIXSRK-YFKPBYRVSA-N 0.000 description 1
- JVTAAEKCZFNVCJ-UHFFFAOYSA-N Lactic Acid Natural products CC(O)C(O)=O JVTAAEKCZFNVCJ-UHFFFAOYSA-N 0.000 description 1
- 102000004895 Lipoproteins Human genes 0.000 description 1
- 108090001030 Lipoproteins Proteins 0.000 description 1
- KDXKERNSBIXSRK-UHFFFAOYSA-N Lysine Natural products NCCCCC(N)C(O)=O KDXKERNSBIXSRK-UHFFFAOYSA-N 0.000 description 1
- 239000004472 Lysine Substances 0.000 description 1
- NTIZESTWPVYFNL-UHFFFAOYSA-N Methyl isobutyl ketone Chemical compound CC(C)CC(C)=O NTIZESTWPVYFNL-UHFFFAOYSA-N 0.000 description 1
- UIHCLUNTQKBZGK-UHFFFAOYSA-N Methyl isobutyl ketone Natural products CCC(C)C(C)=O UIHCLUNTQKBZGK-UHFFFAOYSA-N 0.000 description 1
- FXHOOIRPVKKKFG-UHFFFAOYSA-N N,N-Dimethylacetamide Chemical compound CN(C)C(C)=O FXHOOIRPVKKKFG-UHFFFAOYSA-N 0.000 description 1
- 102000015636 Oligopeptides Human genes 0.000 description 1
- 108010038807 Oligopeptides Proteins 0.000 description 1
- 102000003992 Peroxidases Human genes 0.000 description 1
- 229920000954 Polyglycolide Polymers 0.000 description 1
- 239000004372 Polyvinyl alcohol Substances 0.000 description 1
- BQCADISMDOOEFD-UHFFFAOYSA-N Silver Chemical compound [Ag] BQCADISMDOOEFD-UHFFFAOYSA-N 0.000 description 1
- 229920002472 Starch Polymers 0.000 description 1
- 241000700605 Viruses Species 0.000 description 1
- IKEBXDQECRVZEU-UHFFFAOYSA-N [H+].[H+].[H+].[PH4+].[O-]P([O-])(=O)OP([O-])([O-])=O Chemical compound [H+].[H+].[H+].[PH4+].[O-]P([O-])(=O)OP([O-])([O-])=O IKEBXDQECRVZEU-UHFFFAOYSA-N 0.000 description 1
- RJDOZRNNYVAULJ-UHFFFAOYSA-L [O--].[O--].[O--].[O--].[O--].[O--].[O--].[O--].[O--].[O--].[F-].[F-].[Mg++].[Mg++].[Mg++].[Al+3].[Si+4].[Si+4].[Si+4].[K+] Chemical compound [O--].[O--].[O--].[O--].[O--].[O--].[O--].[O--].[O--].[O--].[F-].[F-].[Mg++].[Mg++].[Mg++].[Al+3].[Si+4].[Si+4].[Si+4].[K+] RJDOZRNNYVAULJ-UHFFFAOYSA-L 0.000 description 1
- 238000010521 absorption reaction Methods 0.000 description 1
- 239000002253 acid Substances 0.000 description 1
- 230000002378 acidificating effect Effects 0.000 description 1
- 150000007513 acids Chemical class 0.000 description 1
- 230000009471 action Effects 0.000 description 1
- 230000002776 aggregation Effects 0.000 description 1
- 238000004220 aggregation Methods 0.000 description 1
- 239000003513 alkali Substances 0.000 description 1
- 125000000539 amino acid group Chemical group 0.000 description 1
- 125000003277 amino group Chemical group 0.000 description 1
- 230000002785 anti-thrombosis Effects 0.000 description 1
- 239000003146 anticoagulant agent Substances 0.000 description 1
- ODKSFYDXXFIFQN-UHFFFAOYSA-N arginine Natural products OC(=O)C(N)CCCNC(N)=N ODKSFYDXXFIFQN-UHFFFAOYSA-N 0.000 description 1
- 239000002473 artificial blood Substances 0.000 description 1
- 229960001230 asparagine Drugs 0.000 description 1
- 235000009582 asparagine Nutrition 0.000 description 1
- 230000001580 bacterial effect Effects 0.000 description 1
- 230000008901 benefit Effects 0.000 description 1
- 229920002988 biodegradable polymer Polymers 0.000 description 1
- 239000004621 biodegradable polymer Substances 0.000 description 1
- 210000004204 blood vessel Anatomy 0.000 description 1
- QVYARBLCAHCSFJ-UHFFFAOYSA-N butane-1,1-diamine Chemical compound CCCC(N)N QVYARBLCAHCSFJ-UHFFFAOYSA-N 0.000 description 1
- 125000003178 carboxy group Chemical group [H]OC(*)=O 0.000 description 1
- 210000000845 cartilage Anatomy 0.000 description 1
- 239000005018 casein Substances 0.000 description 1
- BECPQYXYKAMYBN-UHFFFAOYSA-N casein, tech. Chemical compound NCCCCC(C(O)=O)N=C(O)C(CC(O)=O)N=C(O)C(CCC(O)=N)N=C(O)C(CC(C)C)N=C(O)C(CCC(O)=O)N=C(O)C(CC(O)=O)N=C(O)C(CCC(O)=O)N=C(O)C(C(C)O)N=C(O)C(CCC(O)=N)N=C(O)C(CCC(O)=N)N=C(O)C(CCC(O)=N)N=C(O)C(CCC(O)=O)N=C(O)C(CCC(O)=O)N=C(O)C(COP(O)(O)=O)N=C(O)C(CCC(O)=N)N=C(O)C(N)CC1=CC=CC=C1 BECPQYXYKAMYBN-UHFFFAOYSA-N 0.000 description 1
- 235000021240 caseins Nutrition 0.000 description 1
- 239000003093 cationic surfactant Substances 0.000 description 1
- 108010015046 cell aggregation factors Proteins 0.000 description 1
- 239000001913 cellulose Substances 0.000 description 1
- 229920002678 cellulose Polymers 0.000 description 1
- 229920002301 cellulose acetate Polymers 0.000 description 1
- 239000011248 coating agent Substances 0.000 description 1
- 238000000576 coating method Methods 0.000 description 1
- 239000013065 commercial product Substances 0.000 description 1
- 238000013329 compounding Methods 0.000 description 1
- 238000010276 construction Methods 0.000 description 1
- 239000004035 construction material Substances 0.000 description 1
- 230000003247 decreasing effect Effects 0.000 description 1
- 230000000593 degrading effect Effects 0.000 description 1
- 238000011161 development Methods 0.000 description 1
- 238000010586 diagram Methods 0.000 description 1
- GUJOJGAPFQRJSV-UHFFFAOYSA-N dialuminum;dioxosilane;oxygen(2-);hydrate Chemical compound O.[O-2].[O-2].[O-2].[Al+3].[Al+3].O=[Si]=O.O=[Si]=O.O=[Si]=O.O=[Si]=O GUJOJGAPFQRJSV-UHFFFAOYSA-N 0.000 description 1
- 239000000539 dimer Substances 0.000 description 1
- 239000003814 drug Substances 0.000 description 1
- 238000012377 drug delivery Methods 0.000 description 1
- 238000006911 enzymatic reaction Methods 0.000 description 1
- 238000002474 experimental method Methods 0.000 description 1
- 239000000835 fiber Substances 0.000 description 1
- 239000010408 film Substances 0.000 description 1
- 235000013305 food Nutrition 0.000 description 1
- PCHJSUWPFVWCPO-UHFFFAOYSA-N gold Chemical compound [Au] PCHJSUWPFVWCPO-UHFFFAOYSA-N 0.000 description 1
- 229910052737 gold Inorganic materials 0.000 description 1
- 239000010931 gold Substances 0.000 description 1
- 229910000271 hectorite Inorganic materials 0.000 description 1
- KWLMIXQRALPRBC-UHFFFAOYSA-L hectorite Chemical compound [Li+].[OH-].[OH-].[Na+].[Mg+2].O1[Si]2([O-])O[Si]1([O-])O[Si]([O-])(O1)O[Si]1([O-])O2 KWLMIXQRALPRBC-UHFFFAOYSA-L 0.000 description 1
- 239000005556 hormone Substances 0.000 description 1
- 229940088597 hormone Drugs 0.000 description 1
- 229920002674 hyaluronan Polymers 0.000 description 1
- 229960003160 hyaluronic acid Drugs 0.000 description 1
- 125000002887 hydroxy group Chemical group [H]O* 0.000 description 1
- 230000001771 impaired effect Effects 0.000 description 1
- 239000012770 industrial material Substances 0.000 description 1
- 239000010954 inorganic particle Substances 0.000 description 1
- 229910017053 inorganic salt Inorganic materials 0.000 description 1
- 239000011229 interlayer Substances 0.000 description 1
- 125000003010 ionic group Chemical group 0.000 description 1
- 150000002500 ions Chemical class 0.000 description 1
- NLYAJNPCOHFWQQ-UHFFFAOYSA-N kaolin Chemical compound O.O.O=[Al]O[Si](=O)O[Si](=O)O[Al]=O NLYAJNPCOHFWQQ-UHFFFAOYSA-N 0.000 description 1
- 239000004310 lactic acid Substances 0.000 description 1
- 235000014655 lactic acid Nutrition 0.000 description 1
- JJTUDXZGHPGLLC-UHFFFAOYSA-N lactide Chemical compound CC1OC(=O)C(C)OC1=O JJTUDXZGHPGLLC-UHFFFAOYSA-N 0.000 description 1
- 238000000691 measurement method Methods 0.000 description 1
- 230000007246 mechanism Effects 0.000 description 1
- 239000010445 mica Substances 0.000 description 1
- 229910052618 mica group Inorganic materials 0.000 description 1
- 244000005700 microbiome Species 0.000 description 1
- 239000012046 mixed solvent Substances 0.000 description 1
- 229910052901 montmorillonite Inorganic materials 0.000 description 1
- 229930014626 natural product Natural products 0.000 description 1
- 231100000956 nontoxicity Toxicity 0.000 description 1
- 210000000056 organ Anatomy 0.000 description 1
- 150000002894 organic compounds Chemical class 0.000 description 1
- 239000011368 organic material Substances 0.000 description 1
- 229910052763 palladium Inorganic materials 0.000 description 1
- KJOMYNHMBRNCNY-UHFFFAOYSA-N pentane-1,1-diamine Chemical compound CCCCC(N)N KJOMYNHMBRNCNY-UHFFFAOYSA-N 0.000 description 1
- 108040007629 peroxidase activity proteins Proteins 0.000 description 1
- 229910052698 phosphorus Inorganic materials 0.000 description 1
- 108091005981 phosphorylated proteins Proteins 0.000 description 1
- 230000001766 physiological effect Effects 0.000 description 1
- 229910052697 platinum Inorganic materials 0.000 description 1
- 229920000747 poly(lactic acid) Polymers 0.000 description 1
- 229920002463 poly(p-dioxanone) polymer Polymers 0.000 description 1
- 239000004631 polybutylene succinate Substances 0.000 description 1
- 229920002961 polybutylene succinate Polymers 0.000 description 1
- 239000000622 polydioxanone Substances 0.000 description 1
- 239000004633 polyglycolic acid Substances 0.000 description 1
- 239000004626 polylactic acid Substances 0.000 description 1
- 229920001184 polypeptide Polymers 0.000 description 1
- 229920002451 polyvinyl alcohol Polymers 0.000 description 1
- 238000002360 preparation method Methods 0.000 description 1
- 102000004196 processed proteins & peptides Human genes 0.000 description 1
- 108090000765 processed proteins & peptides Proteins 0.000 description 1
- BDERNNFJNOPAEC-UHFFFAOYSA-N propan-1-ol Chemical compound CCCO BDERNNFJNOPAEC-UHFFFAOYSA-N 0.000 description 1
- 230000004853 protein function Effects 0.000 description 1
- 125000001453 quaternary ammonium group Chemical group 0.000 description 1
- 238000011160 research Methods 0.000 description 1
- 230000000717 retained effect Effects 0.000 description 1
- 239000012266 salt solution Substances 0.000 description 1
- 150000003839 salts Chemical class 0.000 description 1
- 229910000275 saponite Inorganic materials 0.000 description 1
- 239000013535 sea water Substances 0.000 description 1
- 229910052709 silver Inorganic materials 0.000 description 1
- 239000004332 silver Substances 0.000 description 1
- 239000002356 single layer Substances 0.000 description 1
- 229910021647 smectite Inorganic materials 0.000 description 1
- 229910052708 sodium Inorganic materials 0.000 description 1
- 239000011780 sodium chloride Substances 0.000 description 1
- 229940054269 sodium pyruvate Drugs 0.000 description 1
- 239000007779 soft material Substances 0.000 description 1
- 239000002689 soil Substances 0.000 description 1
- 239000002904 solvent Substances 0.000 description 1
- 239000008107 starch Substances 0.000 description 1
- 235000019698 starch Nutrition 0.000 description 1
- 239000000758 substrate Substances 0.000 description 1
- 125000000542 sulfonic acid group Chemical group 0.000 description 1
- 230000008961 swelling Effects 0.000 description 1
- FAGUFWYHJQFNRV-UHFFFAOYSA-N tetraethylenepentamine Chemical compound NCCNCCNCCNCCN FAGUFWYHJQFNRV-UHFFFAOYSA-N 0.000 description 1
- YLQBMQCUIZJEEH-UHFFFAOYSA-N tetrahydrofuran Natural products C=1C=COC=1 YLQBMQCUIZJEEH-UHFFFAOYSA-N 0.000 description 1
- 230000001225 therapeutic effect Effects 0.000 description 1
Images
Classifications
-
- C—CHEMISTRY; METALLURGY
- C08—ORGANIC MACROMOLECULAR COMPOUNDS; THEIR PREPARATION OR CHEMICAL WORKING-UP; COMPOSITIONS BASED THEREON
- C08L—COMPOSITIONS OF MACROMOLECULAR COMPOUNDS
- C08L71/00—Compositions of polyethers obtained by reactions forming an ether link in the main chain; Compositions of derivatives of such polymers
- C08L71/02—Polyalkylene oxides
-
- A—HUMAN NECESSITIES
- A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
- A61L—METHODS OR APPARATUS FOR STERILISING MATERIALS OR OBJECTS IN GENERAL; DISINFECTION, STERILISATION OR DEODORISATION OF AIR; CHEMICAL ASPECTS OF BANDAGES, DRESSINGS, ABSORBENT PADS OR SURGICAL ARTICLES; MATERIALS FOR BANDAGES, DRESSINGS, ABSORBENT PADS OR SURGICAL ARTICLES
- A61L27/00—Materials for grafts or prostheses or for coating grafts or prostheses
- A61L27/50—Materials characterised by their function or physical properties, e.g. injectable or lubricating compositions, shape-memory materials, surface modified materials
- A61L27/52—Hydrogels or hydrocolloids
-
- C—CHEMISTRY; METALLURGY
- C08—ORGANIC MACROMOLECULAR COMPOUNDS; THEIR PREPARATION OR CHEMICAL WORKING-UP; COMPOSITIONS BASED THEREON
- C08L—COMPOSITIONS OF MACROMOLECULAR COMPOUNDS
- C08L2203/00—Applications
- C08L2203/02—Applications for biomedical use
Definitions
- the present invention relates to an organic / inorganic composite hydrogel in which an organic polymer and a clay mineral form a three-dimensional network, and an organic / inorganic composite hydrogel exhibiting degradability in water or in vivo.
- Polymer hydrogels are organic polymer three-dimensional cross-linked products that contain water and swell, and as soft materials with swelling and rubber-like elasticity, such as medical / medicine, food, civil engineering, bioengineering, sports-related, etc. Widely used in the field.
- a polymer hydrogel having a three-dimensional network formed by combining a water-soluble organic polymer and a layered clay mineral has characteristics such as excellent water absorption and extremely high extensibility.
- a polymer of a water-soluble organic monomer having an amide bond is mainly used, and it has been difficult to apply it to polyethylene glycol, which is a polymer having excellent biocompatibility.
- the synthesis of polyethylene glycol hydrogels has been performed using macromers that are structurally designed so that regular chemical crosslinks are formed.
- Non-Patent Document 1 It has been reported that a greatly improved polyethylene glycol hydrogel can be obtained (see, for example, Non-Patent Document 1).
- the resulting polyethylene glycol hydrogel exhibited about 280% stretch and about 50 kPa strength at a polymer concentration of 120 mg / ml (see Comparative Example 1). This is achieved by reacting two kinds of reactive four-chain polyethylene glycols by mixing to obtain a chemically crosslinked polyethylene glycol hydrogel having a uniform molecular weight between crosslinking points.
- the mechanical properties of the obtained polyethylene glycol hydrogel are not yet sufficiently high for practical use, and it is desired to further improve the draw ratio and tensile strength and to control the mechanical properties over a wide range. It was.
- a polymer material that gradually decomposes by being kept in a predetermined atmosphere For example, materials that are gradually decomposed and metabolized after being implanted in the living body, materials that decompose after use for a certain period of time in soil, materials that decompose gradually when placed in a high-temperature or high-humidity atmosphere, use for a certain period of time Examples include materials that later lose shape or mechanical strength due to decomposition, and materials that signal the end of use, and materials that can be decomposed correspondingly when the atmosphere changes.
- the polymer material before decomposing needs to have excellent performance according to the purpose, especially high mechanical properties, flexibility, transparency, safety, processability to various shapes.
- the decomposition conditions are not severe conditions such as high temperature and high pressure, but can be performed under mild conditions as much as possible.
- the decomposition conditions are not severe conditions such as high temperature and high pressure, but can be performed under mild conditions as much as possible.
- biodegradable polymers that are degraded by microorganisms and hydrolyzable polymers that are degraded in water or at high humidity.
- biodegradable polymers that are degraded by microorganisms
- hydrolyzable polymers that are degraded in water or at high humidity.
- polylactic acid, polycaptolactone, polyglycolic acid, polydioxanone, modified polyvinyl alcohol, Polybutylene succinate, glycolic acid / lactic acid copolymer, lactide / caprolactone copolymer, cellulose, hyaluronic acid, cellulose acetate, starch, casein and the like are used.
- polymer gels those using the above-mentioned polymers and polymer gels made of collagen, chitosan, proteins, etc. that are derived from living bodies and are absorbed by living bodies are known. However, it satisfies the above-mentioned high transparency, mechanical properties controlled in a wide range, flexibility, safety, biocompatibility, processability to various shapes, etc. as well as degradability under mild conditions, In addition, there is no one that satisfies all conditions such as non-toxicity after decomposition, and its development has been strongly demanded.
- Non-Patent Document 2 An organic-inorganic composite gel composed of a monomer polymer and a layered peelable inorganic clay mineral has been reported (Patent Document 2, Non-Patent Document 2). However, although the obtained gel has excellent properties, it did not have degradability in water or in vivo. In addition, none of the polymer gels and organic / inorganic composite gels having excellent mechanical properties, flexibility, and transparency reported to others have been known (Non-Patent Documents 1, 3 to 5).
- a protein is a string-like polymer in which amino acids are connected one-dimensionally, and the string is folded to create a specific three-dimensional structure.
- the protein exhibits various functions. Typical examples are enzymes and antibodies.
- Specific examples of functional proteins include amylase, protease, lipase, cellulase, oxidase, dehydrogenase, gelatin, collagen, fibronectin, albumin, IgG, macroglobulin, blood coagulation factor, monoclonal antibody, polyclonal antibody and the like.
- protein functions are expressed on the basis of three-dimensional structures stabilized by non-covalent bonds such as hydrophobic interactions, van der Waals interactions, and hydrogen bonds. Deactivating the function has become a major issue.
- Patent Document 3 a method for obtaining an improved protein by substituting amino acid residues in a protein
- Patent Document 4 a method for obtaining a thermostable protein by obtaining a mutant enzyme
- Patent Document 5 a protein using a cationic surfactant
- sufficient results are not always obtained for effective heat resistance improvement.
- Patent Document 2 US6710104 JP 2009-118749 A JP 2001-78786 A Special table 2004-500005
- the problems to be solved by the present invention include excellent mechanical properties, flexibility, transparency, safety, and in particular, polyethylene glycol whose tensile strength and stretch ratio are greatly improved or controlled over a wide range is an organic component.
- a polymer hydrogel and a method for producing the same are excellent mechanical properties, flexibility, transparency, safety, and in particular, polyethylene glycol whose tensile strength and stretch ratio are greatly improved or controlled over a wide range is an organic component.
- Another object of the present invention is to provide a degradable organic material that satisfies the above-mentioned conditions, which solves the above-mentioned problems and has a property that can be decomposed in a mild atmosphere and that the decomposed components are also non-toxic.
- An object of the present invention is to provide an inorganic composite hydrogel, a method for producing the same, and a biological implant material using the same.
- Another object of the present invention is to provide an organic-inorganic composite hydrogel containing a protein that can increase the thermal stability of the protein and exhibit its function even at a higher temperature, a method for producing the same, and a method for stabilizing the protein. There is.
- the present inventors have uniformly dispersed finely dispersed clay minerals in a cross-linked polyethylene glycol so that they form a three-dimensional network.
- the organic / inorganic composite hydrogel is excellent in mechanical properties such as tensile strength and stretch ratio and controlled in a wide range while maintaining uniformity, and such an organic / inorganic composite. It has been found that the thermal stability of the protein is improved in the hydrogel containing the protein and the degradation product of the gel, and the present invention has been completed.
- the present invention is characterized in that a polymer compound (A) having a branched structure or network structure in which a plurality of polyethylene glycol chains are chemically crosslinked is combined with a layered exfoliated clay mineral (B).
- An organic-inorganic composite hydrogel is provided.
- the present invention also provides an organic-inorganic composite hydrogel containing the protein (C) in the organic-inorganic composite hydrogel or a decomposition product thereof.
- the present invention provides a living body implanting material using the organic-inorganic composite hydrogel.
- the present invention also provides an aqueous dispersion of the clay mineral (B) by layering the clay mineral (B) in an aqueous medium.
- a method for producing the organic-inorganic composite hydrogel described above is provided.
- the present invention also provides a protein stabilization method characterized by improving the stability of the protein (C) by containing the protein (C) in the organic-inorganic composite hydrogel or the decomposition product thereof. To do.
- the organic-inorganic composite hydrogel obtained by the present invention provides an organic / inorganic composite hydrogel having excellent uniformity and stretch mechanical properties by forming a three-dimensional network of layered exfoliated clay mineral and polyethylene glycol.
- an organic / inorganic composite hydrogel comprising polyethylene glycol having excellent transparency, uniformity, stretching strength and elongation as an organic component can be obtained.
- the organic-inorganic composite hydrogel of the present invention is degradable by using, as the polymer compound (A), a compound having an ester group at least in part and having a polyethylene glycol chain chemically cross-linked by an amide bond. Gel. This gel confirms that the degraded product is safe in biological testing. In this case, a degradable gel suitable for in vivo degradation can be obtained by changing the composition such as the content of clay minerals or ester groups.
- the thermal stability of the protein is improved, and for example, the enzyme activity of the enzyme is maintained at a higher temperature for a long time.
- the organic / inorganic composite hydrogel having the above characteristics can be obtained in various shapes including cylindrical, rod-like, film-like and thread-like, and is an artificial valve excellent in biocompatibility and flexibility, especially in the medical and pharmaceutical fields.
- Artificial organ materials such as artificial blood vessels and artificial cartilage, therapeutic materials such as catheters, and single or other biocompatible materials and biodegradable materials, which can be embedded in a living body with excellent safety after degradation. It is used effectively as a material. In addition, it is also used in fields such as agriculture, industry, electronic materials, civil engineering, and packaging materials as various industrial materials having excellent elasticity.
- FIG. 3 is a diagram showing stress-strain curves in a tensile test of organic / inorganic composite hydrogels obtained in Examples 1 to 4 and Comparative Example 1. It is a figure which shows the cytotoxicity test result of the decomposition solution of the hydrogel obtained in Example 9 and Comparative Example 4. It is a figure which shows the stress-strain curve by the extending
- the polymer compound (A) used in the present invention is a polymer compound having a branched structure or network structure in which a plurality of polyethylene glycol chains are chemically crosslinked, and a plurality of linear polyethylene glycols are a plurality of crosslinked molecules. It has a structure connected by points or branch points. Such a structure can be used without particular limitation as long as the effects of the present invention are not impaired.
- a part of the polymer chain has a functional group that causes an interaction with a clay mineral, such as a hydroxyl group, a carboxyl group, an amino group, a sulfonic acid group, an amide group, an ester group, or a quaternary ammonium ion.
- a group into which one or a plurality of ionic groups such as a group is introduced is used.
- the chemical cross-linking of the polymer compound (A) is based on an amide bond, and a compound having a structure having an ester group in a part of the molecular chain is preferable because it is excellent in decomposability. More specifically, it is a polymer compound having a branched structure or network structure in which a polyethylene glycol chain containing an ester group at least partially is chemically cross-linked by an amide bond, and a plurality of linear polyethylene glycols are plural. A compound having a structure connected by a crosslinking point or a branching point.
- the polymer compound (A) used in the present invention includes a compound (a1) having a polyethylene glycol chain and a plurality of reactive functional groups (Q1) in the same molecule, and the reactive functional group (Q1) It can be produced by reacting a compound (a2) having a plurality of reactive functional groups (Q2) capable of reacting.
- compound (a1) or compound (a2) for example, a compound represented by the following formula (4) or formula (5) can be used.
- R is a group represented by the following formula (3), formula (6) to formula (11), and n is an integer of 1 or more. Further, the total of four n in one molecule is preferably 50 to 1000, more preferably 100 to 800, and particularly preferably 150 to 500.
- the weight average molecular weight of the compounds represented by the above formulas (4) and (5) is preferably from 1,000 to 100,000, more preferably from 5,000 to 50,000, and particularly preferably from 5,000 to 40,000.
- R is the type SUNBRIGHT PTE-050GS (weight average molecular weight 5000), PTE-100GS (weight average molecular weight 10,000), PTE-150GS (weight average molecular weight 15000), PTE-200GS (weight average molecular weight) of the above formula (3) 20000), PTE-400GS (weight average molecular weight 40000)
- R is type PTE-100HS (weight average molecular weight 10000), PTE-200HS (weight average molecular weight 20000), PTE-400HS (weight average molecular weight 40000) of the above formula (6)
- R is type PTE-100MA (weight average molecular weight 10000), PTE-200MA (weight average molecular weight 20000), PTE-400MA (weight average molecular weight 40000) of the above formula (8)
- R is type PTE-100PA (weight average molecular weight 10,000), PTE-150PA (weight average molecular weight 15000), PTE-200PA (weight average molecular weight
- any one of the groups represented by the above formulas (3) and (6) to (11) is selected as the reactive functional group (Q1), and can react with the reactive functional group (Q1).
- Reactive functional group (Q2) is selected. And if the compound which has these reactive functional groups (Q1) and (Q2) is made to react as a compound (a1) and a compound (a2), respectively, the high molecular compound (A) which can be used by this invention will be manufactured. Can do.
- any compound is selected from the compounds represented by the above formulas (4) and (5), and this is used as the compound (a1) having a reactive functional group (Q1).
- Compound (a2) is a known compound (C) having a plurality of reactive functional groups (Q2) other than the compounds represented by 4) and formula (5) and having a plurality of reactive functional groups (Q2) capable of reacting with this reactive functional group (Q1).
- the polymer compound (A) that can be used in the present invention can also be produced.
- Examples of such a compound (C) include ethylenediamine, hexamethylenediamine, diethylenetriamine, triethylenetetramine, tetraethylenepentamine, phenylenediamine, butanediamine, pentanediamine, and amino acids such as arginine, asparagine, lysine, and the like. Protein etc. are used.
- polymer compound (A) used in the present invention more preferably, a compound that has been chemically cross-linked so that the molecular weight between cross-linking points is uniform is effectively used.
- polyethylene glycol chemically cross-linked so that the molecular weight between the cross-linking points is uniform include, for example, two reactive 4-chain polyethylene glycols described in Non-Patent Documents 2 and 7 (amine end having an amine at the end)
- examples thereof include polyethylene glycol obtained by mixing and reacting 4-chain polyethylene glycol (TAPEG) and polyethylene glycol having an N-hydroxysuccinimide glutarate terminal at the terminal (TNPEG). In this case, an amide group or an ester group exists in the polyethylene glycol chain.
- the molecular weight between cross-linking points of chemical cross-linking is 1 ⁇ 2 of the molecular weight of the 4-chain polyethylene glycol, but the value is preferably 1000 to 50000, more preferably 2000 to 30000, and particularly preferably 3000 to 20000.
- the value of the molecular weight between cross-linking points is less than 1000, the flexibility is insufficient or the draw ratio is reduced.
- it is larger than 50000 the elastic modulus is too low or the handleability is deteriorated.
- the compound (a1) is a compound represented by the following formula (1)
- the compound (a2) is represented by the following formula (2). It is particularly preferable to use compounds which are both compounds and have a weight average molecular weight of 1,000 to 100,000.
- n is an integer.
- Y is a group represented by —CH 2 CH 2 CH 2 NH 2 , and n is an integer.
- a swellable clay mineral that can be peeled in layers is used, and particularly preferably dispersed in water in a molecular (single layer) or within 1 to 10 layers for uniform dispersion.
- Possible clay minerals are used.
- water-swellable smectite or water-swellable mica is used.
- water-swellable hectorite containing sodium as an interlayer ion, water-swellable montmorillonite, water-swellable saponite, water-swellable synthetic mica, etc. Can be mentioned.
- the layered exfoliated clay mineral (B) and the polymer compound (A) interact to form a three-dimensional network.
- the interaction between the clay mineral and the polymer compound (A) is one or more of ionic bond, hydrogen bond, hydrophobic bond, coordination bond, and covalent bond.
- the amide group and / or ester group of the polymer compound (A) and the clay mineral (B) form a three-dimensional network by hydrogen bonding.
- organic or inorganic functional molecules and particles can be added for the purpose of improving or controlling physical properties, as long as such three-dimensional network formation is not hindered.
- inorganic particles it is effective to use nanoparticles such as silica, titania, zirconia, palladium, silver, gold, and platinum together.
- the mass ratio (B / A) of the clay mineral (B) to the polymer compound (A) is preferably 0.03 to 3, more preferably 0.04 to 1. .5, particularly preferably 0.05 to 0.5.
- the mass ratio is 0.03 or less, improvement of mechanical properties tends to be insufficient, and when it is 3 or more, uniform fine dispersion of the clay mineral is often difficult.
- any of simple proteins including oligopeptides and polypeptides and complex proteins such as glycoproteins, lipoproteins, and phosphorylated proteins can be used. These may be natural products derived from living organisms, artificial synthetic products, or products produced from bacterial cells or the like by DNA recombination. Furthermore, these are preferably functional proteins having some physiological activity, and examples thereof include serum proteins, enzymes, immunoactive substances, antithrombotic substances, cell adhesion factors, hormones, cytokines, bacteria, viruses and the like. .
- functional proteins include amylase, protease, lipase, cellulase, peroxidase, oxidase, dehydrogenase, gelatin, collagen, fibronectin, albumin, IgG, macroglobulin, blood coagulation factor, monoclonal antibody, polyclonal antibody, etc. Is done. One or more of these are selected and used.
- the content of the protein (C) used in the present invention in the organic / inorganic composite hydrogel can be uniformly dispersed but can be set according to the purpose within a concentration range.
- the solvent used for the formation of the protein-containing organic / inorganic composite hydrogel gel of the present invention is water, but as long as the protein-containing gel is formed, it is miscible with water and mixed with water-soluble monomers, clay minerals and proteins in a uniform solution. It is also possible to include an organic solvent that is miscible with the water that forms. Further, as long as a uniform solution is formed, an aqueous solution containing a salt or the like can also be used.
- organic solvent miscible with water examples include methanol, ethanol, propanol, acetone, methyl ethyl ketone, methyl isobutyl ketone, tetrahydrofuran, dimethylacetamide, dimethylformamide, dimethyl sulfoxide, and a mixed solvent thereof.
- the protein-containing organic / inorganic composite gel of the present invention is a gel containing water and protein in a three-dimensional network formed by complexing crosslinked polyethylene glycol chains and clay minerals. That is, proteins interact with each other (ionic interactions, hydrogen bonds, hydrophobic interactions, chelates) in a three-dimensional network formed by complexing crosslinked polyethylene glycol chains and clay minerals in water at the molecular level. It has the characteristics of being dispersed finely by the action of formation, polymer entanglement, etc.
- protein stability is improved by supporting the protein in the organic / inorganic composite gel.
- a protein (enzyme) -containing organic / inorganic composite gel is held in 37 ° C. water and the enzyme activity in the surrounding liquid is measured, the enzyme is simply placed in the 37 ° C. water. In comparison, high enzyme activity is observed over a long period of time. This means that the enzyme was stabilized by supporting the enzyme in the organic / inorganic composite gel and by supporting the enzyme in the degradation product. .
- the organic / inorganic composite hydrogel in the present invention was uniform and transparent regardless of the inorganic content, and no aggregation of clay minerals was observed.
- the final clay mineral content is measured by thermogravimetric analysis (TGA), and the fine dispersibility is measured by transmission electron microscope (TEM) observation.
- TGA thermogravimetric analysis
- TEM transmission electron microscope
- the organic / inorganic composite hydrogel obtained in the present invention is characterized by not only exhibiting excellent mechanical properties but also controlling the mechanical properties in a wide range.
- FIG. 1 change in stress / strain curve in the tensile test of the organic / inorganic composite hydrogel when the clay concentration is changed
- the organic / inorganic composite hydrogel almost always exhibits a breaking elongation of 500% or more.
- polyethylene glycol hydrogel not complexed with clay minerals it showed a large extensibility.
- tensile strength and elastic modulus physical properties were controlled in a wide range including those showing higher tensile strength and elastic modulus than polyethylene glycol hydrogel.
- the organic-inorganic composite hydrogel of the present invention is obtained by using a compound having an ester group at least partially and a polyethylene glycol chain chemically crosslinked by an amide bond as the polymer compound (A).
- This degradable gel has the property of degrading in water, in an aqueous inorganic salt solution such as physiological saline, in an aqueous solution containing an organic compound such as protein, and in an atmosphere such as high humidity or in vivo.
- Decomposition rate varies depending on the atmospheric conditions (eg, atmospheric composition, pH, temperature, and retention time), and also depends on the gel composition (eg, polymer compound composition, clay mineral content, liquid content, medium composition). Change.
- decomposability is often high.
- Degradability is particularly high when the pH of the atmosphere is strongly acidic (for example, pH 3 or lower) and strong alkali (pH 10 or higher).
- pH 3 or lower for example, pH 3 or lower
- strong alkali pH 10 or higher
- the degradation of the present invention also occurs under mild conditions centering on pH 7 during this period. This is a characteristic of degradable gels.
- the composition of the degradable gel in the present invention as a general tendency, the larger the amount of clay mineral, the higher the degradability, and the higher the liquid content, the higher the degradability.
- the gel containing no ester group has no or very low decomposability, and preferably the molar ratio of the ester group to the amide bond is 0.1 to 2.
- the molar ratio of the ester group to the amide bond is 0.1 or less, the decomposability is often insufficient, and when the ratio is 2 or more, it is often difficult to form a uniform gel with high mechanical properties.
- water or an aqueous solution is used as the medium composition of the gel.
- a gel containing phosphoric acid or pyrophosphoric acid is preferably used in order to improve the decomposability.
- pyrophosphoric acid may be unsuitable for applications that place importance on the biological safety (eg, cytotoxicity) of degradation products, and water or aqueous solutions containing phosphoric acid are preferred, with water being particularly preferred. .
- the degradation mechanism of the degradable gel in the present invention is not necessarily limited, but it is presumed that the degradation is mainly at the ester group and / or amide group, particularly at the ester group. Further, when the clay mineral (B) is not included, it is presumed that the interaction between these functional groups and the clay mineral works effectively on the decomposability because it has no or very low degradability.
- the organic / inorganic composite hydrogel in the present invention is preferably prepared by previously mixing an aqueous solution of a compound having a polyethylene glycol chain and a plurality of reactive functional groups in the same molecule with a layered exfoliated clay mineral aqueous dispersion, A compounding technique is used that promotes the crosslinking reaction of the compound. More preferably, in order to obtain an organic / inorganic composite hydrogel having excellent uniformity and mechanical properties, the following is performed which is different from the conventionally reported method for synthesizing polyethylene glycol hydrogel (see Non-Patent Document 2). (1) Use a solution prepared by adding hydrochloric acid to sodium pyrophosphate to adjust the pH.
- a buffer using pyrophosphate is more effectively used than a commonly used phosphate buffer.
- the pH adjusted by adding hydrochloric acid to sodium pyrophosphate also known as sodium diphosphate
- Pyrophosphate is a dimer of phosphoric acid that is generally used.
- phosphorus pyrophosphate is used to stably delaminate clay minerals and to improve the mechanical properties of the resulting polyethylene glycol hydrogel and organic / inorganic composite hydrogel. Works more effectively than acids.
- pyrophosphoric acid is not always necessary. In particular, when the safety of decomposition products is important, it is preferably removed by washing with water.
- a method of combining polyethylene glycol and layered exfoliated clay mineral it is preferable to use a mixture of polymer compound (A) and layered exfoliated clay mineral in advance, more preferably layered exfoliated clay mineral is more stable. It can be mixed with one reactive 4-chain polyethylene glycol (in the case of Non-Patent Document 2, amine-terminated polyethylene glycol) and then mixed with another reactive 4-chain polyethylene glycol and reacted. Used. In the above reaction, the use of pyrophosphoric acid as a buffer and the clay mineral / polyethylene glycol mass ratio of 0.03 to 3 are used in combination, and organic and inorganic having both excellent uniformity and mechanical properties. A composite hydrogel is obtained.
- the degradable gels obtained in the present invention have in-vivo safety and biocompatibility, and can be used as degradable biological implant materials and drug delivery systems.
- the degradable gel in the present invention can be used in various shapes depending on the purpose such as columnar shape, rod shape, film shape, and thread shape at the time of embedding. And the clay mineral concentration and liquid content).
- the degradable gel obtained in the present invention can be used alone or in combination with a synthetic or natural biocompatible material or biodegradable material having other particle, fiber, film, mesh, or coating forms. When combined, it is effectively used as a bio-implanting material excellent in handleability, mechanical properties, biocompatibility, biodegradability, and safety after degradation.
- the degradable gel in the present invention it is also possible to include compounds that are significant for the living body in the degradable gel and to release them gradually along with the degradation.
- it is effectively used as a material taking advantage of degradability in the medical / pharmaceutical field other than the bio-implantation field, and in other industrial fields (for example, fields such as agriculture, industry, electronic materials, civil engineering construction, and packaging materials).
- Example 1 The clay mineral is washed with a water-swellable synthetic hectorite (trademark Laponite XLG, manufactured by Rockwood) having a composition of [Mg 5.34 Li 0.66 Si 8 O 20 (OH) 4 ] Na + 0.66 Thereafter, it was lyophilized before use.
- Reactive four-chain polyethylene glycol uses SUNBRIGHT PTE200GS (hereinafter abbreviated as PTE200GS) and SUNBRIGHT PTE200PA (weight average molecular weight 20000, hereinafter abbreviated as PTE200PA) (both manufactured by NOF Corporation) having a weight average molecular weight of 20000. It was.
- Laponite XLG (0.064 g) was dispersed in 3 ml of an aqueous solution adjusted to pH 7.4 by adding hydrochloric acid to 100 mM sodium pyrophosphate (anhydrous) (also known as sodium diphosphate).
- 240 mg of PTE200PA was added and mixed uniformly.
- hydrochloric acid was added to 100 mM sodium pyrophosphate
- 240 mg of PTE200GS was dissolved in 1 ml of an aqueous solution adjusted to pH 7.2.
- the obtained PTE200PA / clay aqueous solution and PTE200GS aqueous solution were cooled in an ice bath, mixed, and stirred vigorously for 15 seconds.
- the mixed solution was filled in an 80 ⁇ 50 ⁇ 1 mm glass container and reacted at 25 ° C. for 2 hours. As a result, a transparent and homogeneous hydrogel was obtained.
- the obtained hydrogel was washed in 800 ml of water (20 ° C.) while changing water four times in the middle. As a result of fluorescent X-ray measurement, no outflow of polyethylene glycol and clay mineral was observed during the cleaning process. Further, after the hydrogel was dried, thermal mass analysis up to 800 ° C. (TG-DTA220 manufactured by Seiko Denshi Kogyo Co., Ltd .: air flow, temperature increase: 10 ° C./min) was performed to determine the clay content. The clay content (clay mineral / total solid content) was 12.8% by mass, which almost coincided with the calculated value (11.8% by mass) from the reaction solution composition.
- Examples 2 to 4 The synthesis was performed in the same manner as in Example 1 except that 0.032 g (Example 2), 0.32 g (Example 3) and 0.64 g (Example 4) of clay mineral (Laponite XLG) were used. As a result, all have the same composition as calculated from the reaction solution composition, and the mass ratio of clay mineral / polyethylene glycol is 0.067 (Example 2), 0.67 (Example 3), 1.34 (Examples). 4) A uniform and transparent organic / inorganic composite hydrogel was obtained. However, Example 4 is translucent. The result of the tensile test measured in the same manner as in Example 1 is also shown in FIG. The elongation at break was controlled in a wide range from 700 to 1020%, the break strength from 50 to 170 kPa, and the elastic modulus from 28 to 12 kPa.
- Example 9 The clay mineral is washed with a water-swellable synthetic hectorite (trademark Laponite XLG, manufactured by Rockwood) having a composition of [Mg 5.34 Li 0.66 Si 8 O 20 (OH) 4 ] Na + 0.66 Thereafter, it was lyophilized before use.
- Reactive four-chain polyethylene glycol uses SUNBRIGHT PTE200GS (hereinafter abbreviated as PTE200GS) and SUNBRIGHT PTE200PA (weight average molecular weight 20000, hereinafter abbreviated as PTE200PA) (both manufactured by NOF Corporation) having a weight average molecular weight of 20000. It was. Note that PTE200GS contains one ester group in a single chain.
- Laponite XLG 0.64 g of Laponite XLG was dispersed in 30 ml of an aqueous solution adjusted to pH 7.4 by adding hydrochloric acid to 100 mM sodium pyrophosphate (anhydrous) (also known as sodium diphosphate).
- hydrochloric acid was added to 100 mM sodium pyrophosphate
- 2.4 g of PTE200GS was dissolved in 10 ml of an aqueous solution adjusted to pH 7.2.
- the obtained PTE200PA / clay aqueous solution and PTE200GS aqueous solution were cooled in an ice bath, mixed, and stirred vigorously for 15 seconds.
- the mixed solution was filled in several 80 ⁇ 50 ⁇ 2 mm glass containers and reacted at 25 ° C. for 2 hours.
- two reactive 4-chain polyethylene glycols were chemically cross-linked by amide bonds, and a transparent and homogeneous hydrogel was obtained.
- the obtained hydrogel was washed in 800 ml of water (20 ° C.) for 20 hours while changing water four times in the middle. As a result of fluorescent X-ray measurement, no outflow of polyethylene glycol and clay mineral was observed during the cleaning process. Further, after the hydrogel was dried, thermal mass analysis up to 800 ° C. (TG-DTA220 manufactured by Seiko Denshi Kogyo Co., Ltd .: air flow, temperature increase: 10 ° C./min) was performed to determine the clay content. The clay content (clay mineral / polymer) was 13.0% by mass, which almost coincided with the calculated value (13.4% by mass) from the reaction solution composition.
- FT-IR Fourier transform infrared absorption spectrum
- the obtained washed organic / inorganic composite gel was cut into a size of 5 ⁇ 5 ⁇ 2 mm, and was washed in water at 20 ° C. (Example 9), 37 ° C. (Example 10), and 60 ° C. (Example 11). (100 g water / 1 g gel), and after a certain period of time, it is filtered with a SUS filter (mesh # 400), and the mass fraction (percentage) of the recovered gel solids to the solids of the first gel Degradability was evaluated. As a result, the mass fraction of the gel collected in 125 days in Example 9, 16 days in Example 10, and 4 days in Example 11 was almost 0%, and the organic / inorganic composite gel was decomposed under these conditions.
- the liquid obtained by decomposing the gel is added to the medium (5% FBS, 1% sodium pyruvate, 1% P / S, MEM) so that the gel component contained in the medium is 0 to 1000 ppm.
- the cytotoxicity test was conducted using V79 cells (125 cells / 5 ml / dish). None of Examples 9 to 11 showed cytotoxicity (the cytotoxicity evaluation results of Example 9 are shown in FIG. 2).
- Example 12 The organic / inorganic composite gel obtained by synthesizing in the same manner as in Example 9 except that 0.48 g of Laponite XLG was used was cut into 80 ⁇ 10 ⁇ 2 mm, and then put into a glass hermetic container (50 ml), and 60 ° C. 5 hours (Example 12) and 24 hours (Example 13), after holding in a thermostatic chamber, the sample was taken out and subjected to a stretching test in the same manner as in Example 9. As a result, as shown in FIG. 3, compared to the gel that was not held in the 60 ° C. hermetically sealed container, the strength and elastic modulus decreased in Example 12, and in Example 13, the shape of the gel began to collapse, In addition, it was weak and could not be stretched.
- Example 14 to 16 An organic-inorganic composite gel washed with water was obtained in the same manner as in Example 9 except that 1.6 g (Examples 14 and 15) or 3.2 g (Example 16) of Laponite XLG was used. Thereafter, in the same manner as in Example 9, the mass fraction of the recovered gel was measured by keeping it in water at 37 ° C. in Example 14 and Example 16, and in 60 ° C. in Example 15. As a result, the mass fraction of the recovered gel was 0% in 12.5 days in Example 14, 2.4 days in Example 15, and 9 days in Example 16, and the gel was almost decomposed. Was observed.
- Example 17 The organic / inorganic composite gel synthesized in Example 9 and washed with water was kept in 37 ° C. physiological saline instead of in water, and the gel was decomposed in the same manner as in Example 9. evaluated. As a result, the mass fraction of the collected gel became 0% after 7.5 days.
- Example 18 The organic-inorganic composite gel obtained by synthesis in Example 9 was washed in water for 20 hours, then in Example 18 in a 100 mM phosphate buffer aqueous solution (pH 7.4), and in Example 19 100 mM pyrophosphate. It was immersed in a buffer aqueous solution (pH 7.4) for 4 hours. The obtained gel was held in 37 ° C. water in the same manner as in Example 10 to evaluate the degradability of the gel. As a result, the mass fraction of the gel recovered after 14 days in Example 18 and 13 days in Example 19 was 0%, confirming faster degradability than in the case of only water washing (Example 10). .
- Comparative Example 3 it was observed that the gel was degraded after 10 days. As a result of performing the cytotoxicity test of the obtained degradation solution in the same manner as in Example 11, cytotoxicity was observed. .
- the results of the cytotoxicity test in Comparative Example 3 are shown in FIG.
- Example 20 Instead of SUNBRIGHT PTE200GS containing one ester group in one ethylene glycol chain, the same procedure as in Example 9 was used except that SUNRIGHT PTE200HS (made by NOF Corporation) having the same molecular weight and no ester group was used.
- An organic / inorganic composite gel was prepared to produce the organic / inorganic composite gel of Example 20.
- Example 20 Thereafter, in the same manner as in Example 9, the decomposability in water of the washed organic-inorganic composite gel was evaluated. As a result, the gel of Example 20 could not be confirmed to be decomposed by evaluation for one month.
- Example 21 Comparative Example 7
- Example 21 the organic / inorganic composite gel synthesized in Example 9 and washed with water was used.
- Comparative Example 7 the gel synthesized in Comparative Example 1 and washed with water was used.
- Example 21 when the sample was taken under the skin of the goat and taken out one month later, it was decomposed to such a degree that a slight amount of gel residue was seen, whereas in Comparative Example 7, the same shape in the initial stage of implantation was firmly observed. A gel was obtained.
- Example 22 The clay mineral is washed with a water-swellable synthetic hectorite (trademark Laponite XLG, manufactured by Rockwood) having a composition of [Mg 5.34 Li 0.66 Si 8 O 20 (OH) 4 ] Na + 0.66 Thereafter, it was lyophilized before use.
- Reactive four-chain polyethylene glycol uses SUNBRIGHT PTE200GS (hereinafter abbreviated as PTE200GS) and SUNBRIGHT PTE200PA (weight average molecular weight 20000, hereinafter abbreviated as PTE200PA) (both manufactured by NOF Corporation) having a weight average molecular weight of 20000. It was.
- Laponite XLG 0.16 g was dispersed in 3 ml of an aqueous solution adjusted to pH 7.4 by adding hydrochloric acid to 100 mM sodium pyrophosphate (anhydrous) (also known as sodium diphosphate).
- hydrochloric acid 100 mM sodium pyrophosphate (anhydrous) (also known as sodium diphosphate).
- HRP enzyme Horse radish peroxidase: hemeprotein: molecular weight 44000, EC No. 1.11.1.7
- hydrochloric acid was added to 100 mM sodium pyrophosphate
- 240 mg of PTE200GS was dissolved in 1 ml of an aqueous solution adjusted to pH 7.2.
- 1 g of the obtained gel was cut out, put into 100 ml of water (37 ° C.) and held for 12 days. 200 ⁇ l of liquid was sampled at predetermined time intervals during 12 days, and enzyme activity was measured. In the measurement method, the sampled solution was kept at 37 ° C., and STE buffer (composition: 100 mM Tris-HCl, pH 8.0, 1 M NaCl, 10 mM EDTA) 5 ⁇ l, solution 45 ⁇ l, TMB (3, 3 ′, 5, 5 '-tetramethylbenzidine) substrate (50 ⁇ l) was added and reacted at 25 ° C. for 1 minute.
- STE buffer composition: 100 mM Tris-HCl, pH 8.0, 1 M NaCl, 10 mM EDTA
- Example 23, Comparative Example 10 The HRP enzyme-containing organic / inorganic composite gel obtained in Example 22 was transferred to a sealed container, and in Example 23, it was stored at 37 ° C. for 4 days. Thereafter, 1 g of the gel was immersed in 100 g of water (37 ° C.) and held for 1 day, and water was sampled to measure enzyme activity in the same manner as in Example 22. In Comparative Example 10, HRP was kept in 37 ° C. water for 4 days, and further kept in 37 ° C. water for 1 day, and then the water was sampled and the enzyme activity was similarly examined. In addition, the enzyme activity retention rate of Example 23 and Comparative Example 10 was displayed with the value measured before maintaining at 37 ° C. as 100%. Example 23 showed higher activity than Comparative Example 10.
Landscapes
- Chemical & Material Sciences (AREA)
- Health & Medical Sciences (AREA)
- Medicinal Chemistry (AREA)
- General Health & Medical Sciences (AREA)
- Veterinary Medicine (AREA)
- Oral & Maxillofacial Surgery (AREA)
- Transplantation (AREA)
- Epidemiology (AREA)
- Life Sciences & Earth Sciences (AREA)
- Animal Behavior & Ethology (AREA)
- Dispersion Chemistry (AREA)
- Public Health (AREA)
- Dermatology (AREA)
- Chemical Kinetics & Catalysis (AREA)
- Polymers & Plastics (AREA)
- Organic Chemistry (AREA)
- Compositions Of Macromolecular Compounds (AREA)
- Polyethers (AREA)
- Biological Depolymerization Polymers (AREA)
- Materials For Medical Uses (AREA)
Abstract
La présente invention a pour objet un hydrogel macromoléculaire, contenant du polyéthylène glycol en tant que composant organique, et qui possède des propriétés mécaniques, une flexibilité, et une transparence améliorées et une résistance à la traction et un rapport détirement particulièrement améliorés. Lhydrogel macromoléculaire se décompose dans une atmosphère modérée mais les composants de post-décomposition sont non toxiques, lhydrogel peut ainsi être utilisé en tant que matériau pour bio-implants. Aussi, des protéines peuvent être incorporées dans lhydrogel macromoléculaire ; les protéines incorporées sont stabilisées thermiquement, et sont donc capables de fonctionner même à des températures supérieures. Lhydrogel composite organique/inorganique est un conjugué : dun composé macromoléculaire (A), comprenant une structure ramifiée ou une structure en réseau, une pluralité de chaînes polyéthylène glycol étant chimiquement réticulées ; et dun minéral argileux (B), qui a subi une séparation lamellaire. La présente invention concerne également un procédé de production pour lhydrogel macromoléculaire.
Applications Claiming Priority (4)
Application Number | Priority Date | Filing Date | Title |
---|---|---|---|
JP2009-186469 | 2009-08-11 | ||
JP2009186469 | 2009-08-11 | ||
JP2010110121A JP4704506B2 (ja) | 2009-08-11 | 2010-05-12 | 有機無機複合ヒドロゲルおよびその製造方法 |
JP2010-110121 | 2010-05-12 |
Publications (1)
Publication Number | Publication Date |
---|---|
WO2011018995A1 true WO2011018995A1 (fr) | 2011-02-17 |
Family
ID=43586172
Family Applications (1)
Application Number | Title | Priority Date | Filing Date |
---|---|---|---|
PCT/JP2010/063371 WO2011018995A1 (fr) | 2009-08-11 | 2010-08-06 | Hydrogel composite organique/inorganique et son procédé de production |
Country Status (2)
Country | Link |
---|---|
JP (1) | JP4704506B2 (fr) |
WO (1) | WO2011018995A1 (fr) |
Cited By (2)
Publication number | Priority date | Publication date | Assignee | Title |
---|---|---|---|---|
WO2018164003A1 (fr) * | 2017-03-09 | 2018-09-13 | 日産化学株式会社 | Hydrogel sensible à la température et son procédé de production |
WO2019088289A1 (fr) * | 2017-11-06 | 2019-05-09 | 国立大学法人群馬大学 | Hydrogel autoportant et procédé de production associé |
Families Citing this family (8)
Publication number | Priority date | Publication date | Assignee | Title |
---|---|---|---|---|
WO2014046124A1 (fr) | 2012-09-18 | 2014-03-27 | 独立行政法人理化学研究所 | Procédé pour faire adhérer des hydrogels |
JP2014224194A (ja) * | 2013-05-16 | 2014-12-04 | 日産化学工業株式会社 | カチオン型水溶性高分子およびそれよりなるハイドロゲル |
JP6182019B2 (ja) * | 2013-08-21 | 2017-08-16 | 国立研究開発法人国立循環器病研究センター | 高分子化造影剤 |
WO2015076205A1 (fr) * | 2013-11-20 | 2015-05-28 | 日産化学工業株式会社 | Procédé de liaison d'hydrogels |
JP6435557B2 (ja) * | 2017-08-10 | 2018-12-12 | 日産化学株式会社 | カチオン型水溶性高分子およびそれよりなるハイドロゲル |
JP7106850B2 (ja) | 2017-12-07 | 2022-07-27 | 株式会社リコー | 超音波検査用ファントム及びその製造方法 |
JP7205819B2 (ja) * | 2018-08-01 | 2023-01-17 | 学校法人甲南学園 | 生体組織修復剤 |
JP7466840B2 (ja) | 2020-07-31 | 2024-04-15 | 株式会社リコー | ハイドロゲル立体造形用組成物、ハイドロゲル立体造形物の造形方法、及びハイドロゲル立体造形用組成物セット |
Citations (5)
Publication number | Priority date | Publication date | Assignee | Title |
---|---|---|---|---|
JP2003510375A (ja) * | 1998-01-07 | 2003-03-18 | デビオ ルシェルシュ ファルマシュティーク ソシエテ アノニム | 分解性のヘテロ二官能性ポリ(エチレングリコール)アクリレート及びそれから誘導されるゲル及び複合体 |
JP2006028446A (ja) * | 2004-07-21 | 2006-02-02 | Dainippon Ink & Chem Inc | 有機・無機複合高分子ゲル及びその製造方法 |
JP2007204527A (ja) * | 2006-01-31 | 2007-08-16 | Kawamura Inst Of Chem Res | 高分子複合ゲル及びその製造方法 |
JP2008100941A (ja) * | 2006-10-18 | 2008-05-01 | Toyama Prefecture | ポリグリセロールデンドリマーの3次元架橋物及び3次元架橋方法、並びにこれを用いたヒドロゲル、薬物送達システム |
JP2009256629A (ja) * | 2008-03-17 | 2009-11-05 | Kawamura Inst Of Chem Res | 有機無機複合ヒドロゲル及びその製造方法 |
-
2010
- 2010-05-12 JP JP2010110121A patent/JP4704506B2/ja not_active Expired - Fee Related
- 2010-08-06 WO PCT/JP2010/063371 patent/WO2011018995A1/fr active Application Filing
Patent Citations (5)
Publication number | Priority date | Publication date | Assignee | Title |
---|---|---|---|---|
JP2003510375A (ja) * | 1998-01-07 | 2003-03-18 | デビオ ルシェルシュ ファルマシュティーク ソシエテ アノニム | 分解性のヘテロ二官能性ポリ(エチレングリコール)アクリレート及びそれから誘導されるゲル及び複合体 |
JP2006028446A (ja) * | 2004-07-21 | 2006-02-02 | Dainippon Ink & Chem Inc | 有機・無機複合高分子ゲル及びその製造方法 |
JP2007204527A (ja) * | 2006-01-31 | 2007-08-16 | Kawamura Inst Of Chem Res | 高分子複合ゲル及びその製造方法 |
JP2008100941A (ja) * | 2006-10-18 | 2008-05-01 | Toyama Prefecture | ポリグリセロールデンドリマーの3次元架橋物及び3次元架橋方法、並びにこれを用いたヒドロゲル、薬物送達システム |
JP2009256629A (ja) * | 2008-03-17 | 2009-11-05 | Kawamura Inst Of Chem Res | 有機無機複合ヒドロゲル及びその製造方法 |
Non-Patent Citations (3)
Title |
---|
FUKASAWA, M. ET AL.: "Synthesis and Mechanical Properties of a Nanocomposite Gel Consisting of a Tetra-PEG/Clay Network", MACROMOLECULES, vol. 43, no. 9, 15 April 2010 (2010-04-15), pages 4370 - 4378 * |
LEE, W. ET AL.: "Effect of Bentonite on the Physical Properties and Drug-Release Behavior of Poly(AA-co-PEGMEA)/Bentonite Nanocomposite Hydrogels for Mucoadhesive", J APPL POLYM SCI, vol. 91, no. 5, 2004, pages 2934 - 2941, XP002453766 * |
SAKAI, T. ET AL.: "Design and Fabrication of a High-Strength Hydrogel with Ideally Homogeneous Network Structure from Tetrahedron-like Macromonomers", MACROMOLECULES, vol. 41, no. 14, 2008, pages 5379 - 5384 * |
Cited By (2)
Publication number | Priority date | Publication date | Assignee | Title |
---|---|---|---|---|
WO2018164003A1 (fr) * | 2017-03-09 | 2018-09-13 | 日産化学株式会社 | Hydrogel sensible à la température et son procédé de production |
WO2019088289A1 (fr) * | 2017-11-06 | 2019-05-09 | 国立大学法人群馬大学 | Hydrogel autoportant et procédé de production associé |
Also Published As
Publication number | Publication date |
---|---|
JP2011057962A (ja) | 2011-03-24 |
JP4704506B2 (ja) | 2011-06-15 |
Similar Documents
Publication | Publication Date | Title |
---|---|---|
WO2011018995A1 (fr) | Hydrogel composite organique/inorganique et son procédé de production | |
Akrami-Hasan-Kohal et al. | Development of reinforced aldehyde-modified kappa-carrageenan/gelatin film by incorporation of halloysite nanotubes for biomedical applications | |
Akhavan-Kharazian et al. | Preparation and characterization of chitosan/gelatin/nanocrystalline cellulose/calcium peroxide films for potential wound dressing applications | |
Kouser et al. | Modified halloysite nanotubes with Chitosan incorporated PVA/PVP bionanocomposite films: Thermal, mechanical properties and biocompatibility for tissue engineering | |
Zhao et al. | Epichlorohydrin-cross-linked hydroxyethyl cellulose/soy protein isolate composite films as biocompatible and biodegradable implants for tissue engineering | |
Yu et al. | Preparation, characterization, and antibacterial properties of biofilms comprising chitosan and ε-polylysine | |
Cao et al. | Injectable drug-loaded polysaccharide hybrid hydrogels for hemostasis | |
Ghanbari et al. | In vitro study of alginate–gelatin scaffolds incorporated with silica NPs as injectable, biodegradable hydrogels | |
Zhuang et al. | Anti-degradation gelatin films crosslinked by active ester based on cellulose | |
Yan et al. | Fabrication of injectable hydrogels based on poly (l-glutamic acid) and chitosan | |
Zhou et al. | Sustainable, high-performance, and biodegradable plastics made from chitin | |
Teng et al. | Weak hydrogen bonds lead to self-healable and bioadhesive hybrid polymeric hydrogels with mineralization-active functions | |
Bispo et al. | Biocompatibility of nanostructured chitosan/poly (vinyl alcohol) blends chemically crosslinked with genipin for biomedical applications | |
Panwar et al. | Tunable, conductive, self-healing, adhesive and injectable hydrogels for bioelectronics and tissue regeneration applications | |
Yeasmin et al. | Fabrication and characterization of pullulan-based nanocomposites reinforced with montmorillonite and tempo cellulose nanofibril | |
Balcioglu et al. | Design of xylose-based semisynthetic polyurethane tissue adhesives with enhanced bioactivity properties | |
Chen et al. | Enhanced skin adhesive property of hydrophobically modified poly (vinyl alcohol) films | |
Tomé et al. | Bioactive transparent films based on polysaccharides and cholinium carboxylate ionic liquids | |
Jaberifard et al. | A novel insoluble film based on crosslinked-starch with gelatin containing ZnO-loaded halloysite nanotube and bacterial nanocellulose for wound healing applications | |
Wang et al. | Formation of composite hydrogel of carboxymethyl konjac glucomannan/gelatin for sustained release of EGCG | |
Lee et al. | Collagen–silica xerogel nanohybrid membrane for guided bone regeneration | |
KR20160072652A (ko) | 단백질-고분자-그래핀 옥사이드 나노복합체 및 이를 포함하는 필름 | |
WO2012105685A1 (fr) | Hydrogel produit à partir d'un dérivé de chitosane | |
Islam et al. | Fabrication and performance characteristics of tough hydrogel scaffolds based on biocompatible polymers | |
Medvecky | Microstructure and properties of polyhydroxybutyrate‐chitosan‐nanohydroxyapatite composite scaffolds |
Legal Events
Date | Code | Title | Description |
---|---|---|---|
121 | Ep: the epo has been informed by wipo that ep was designated in this application |
Ref document number: 10808178 Country of ref document: EP Kind code of ref document: A1 |
|
NENP | Non-entry into the national phase |
Ref country code: DE |
|
122 | Ep: pct application non-entry in european phase |
Ref document number: 10808178 Country of ref document: EP Kind code of ref document: A1 |